approval · primary record
ADALIMUMAB-ATTO
FDA · BLA · 2025-10-16
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-10-16 |
| Brand | AMJEVITA |
| Sponsor | AMGEN INC |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:22.322Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ADALIMUMAB-ATTO:2025-10-16
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.